Skip to main content
Clinical Trials/DRKS00025476
DRKS00025476
Completed
Phase 2

CoreNAVI - Feasability of a patient navigation programme - CoreNAVI

Charité Campus Virchow-Klinikum0 sites312 target enrollmentJune 4, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
C97
Sponsor
Charité Campus Virchow-Klinikum
Enrollment
312
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 4, 2021
End Date
October 31, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Charité Campus Virchow-Klinikum

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnosis of stroke/TIA (ICD\-10 Codes: G45\.x, I60\.x, I61\.x, I63\.x, I64\.x, H34\.x, H47\.0\)
  • Confirmed diagnosis of lung cancer (ICD\-10 Codes: C34\.1, C34\.2, C34\.3, C34\.8, C34\.9, C97\)
  • caregiver of a patient with stroke/lung cancer (after consent of the patient or if legal guardianship consists)
  • Age: \=18 years
  • living in Berlin or Brandenburg

Exclusion Criteria

  • patients living in nursing care facility
  • patient without caregiver and not able to give informed consent and for which no legal guardianship is in place
  • dementia (inclusion of caregiver may be possible)
  • language barrier (inclusion of caregiver may be possible)

Outcomes

Primary Outcomes

Not specified

Similar Trials